Outsourced Biomanufacturing
April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.
Bioprocessing
Samsung Biologics Acquires GSK’s Manufacturing Facility in Maryland, US
The acquisition marks Samsung Biologics’ geographical diversification, establishing its first US manufacturing presence and expanding regional client support.
The Next Phase of Cell Line Development
In this interview, industry experts explain why cell line development timelines are governed by biology—and how the focus is shifting from time compression to smarter optimization.
Leading CROs and CDMOs Turn to Mass Photometry for Rapid Protein, mRNA and Viral Vector Analytics
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability.
AsymBio Launches End-to-End Tech Platforms for Biopharma Lifecycle
AsymBio, a subsidiary of Asymchem Group, has established integrated technology platforms including cell line development, upstream/downstream processing, conjugation toolbox, and analytics.
Fujifilm Biotechnologies Unveils Biomanufacturing & Process Development UK Expansion
Fujifilm Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing of innovative medicines and vaccines in the United Kingdom.
WuXi Biologics Boosts Complex Biologics Pipeline
WuXi Biologics partners with Sinorda on bispecific antibodies for autoimmune diseases and HanchorBio on fusion proteins for oncology and immunology.
Cell Line Development & Upstream Bioprocessing
Tomorrow’s Biologics: Innovation, Intensification, and Precision in Cell Line & Upstream Processing - Now On-Demand!
AGC Biologics Partners with Rarity PBC to Commercialize Breakthrough Gene Therapy
AGC Biologics has partnered with Rarity PBC to provide development and GMP manufacturing of a gene therapy aimed at treating a rare, life-threatening immune disorder.
A Balanced Model for the Future of Life Sciences
Following the acquisition of MCE Pharma Brenntag is building a unique position in both traditional pharma and biopharma.
Merck Acquires Chromatography Business from JSR Life Sciences
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Fujifilm Biotechnologies Opens its Commercial-Scale Cell Culture US Manufacturing Site
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
Siegfried Opens cGMP Viral Vectors Manufacturing Facility
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Merck Opens Life Science Production Plant in Ireland
Merck's first climate-neutral production facility has opened at its Blarney site in Cork, Ireland. The €150 million new building is part of the group's €440 million investment program in Ireland.
Strategic Perspectives on Life Sciences Industry Transformation
Asahi Kasei Life Science emerges as a new growth driver, uniting bioprocess solutions, CRO, and CDMO services to shape the future of healthcare under President Ken Shinomiya’s leadership.
Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development
Download this complimentary Expert Insights eBook today!
Vaccine Manufacturing
Connect with professionals on vaccine manufacturing's next big trends!
Bottleneck Factors in E-Kerosene Production
A new study analyzes the material requirements for synthetic kerosene.
Oligonucleotide Impurity Analysis Using Hydrophilic Interaction Chromatography (HILIC)
Download this complimentary how-to guide today!
Enhancing Biomolecular Insights with Analytical Ultracentrifugation
This Expert Insights eBook hopes to provide scientists with more information on analytical ultracentrifugation (AUC), allowing you to further your research in this field.
Bionova Scientific Opens New pDNA Facility in Texas
Bionova Scientific has opened a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
Asahi Kasei Expands Planova Production with New Spinning Plant
Asahi Kasei Life Science, a division of global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.
Wacker Opens Biotechnology Center in Munich
In a new building at the Wacker Consortium, the company's central research site, researchers are working on new manufacturing processes for biopharmaceuticals and ingredients for food and nutritional supplements.
Sanofi Builds Modern Office at BioCampus Frankfurt
The biopharmaceutical company Sanofi in Germany and the industrial park operator Infraserv Höchst laid the foundation stone for a state-of-the-art office building in the south of the industrial park.
AGC Biologics Expands Cell Therapy Development Operations to Asia
AGC Biologics began its cell therapy process development and clinical manufacturing services on July 1, 2025, at its Yokohama Technical Center in Japan.
BASF Opens New GMP Center in Michigan, US
BASF has opened a new Good Manufacturing Practice (GMP) Solution Center in Wyandotte, Michigan, to support the supply of bioprocessing ingredients and excipients for the biopharma and pharmaceutical industries.
Ecolab Life Sciences Opens Bioprocessing Laboratory in US
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in Pennsylvania.
Hovione and Firstgene Announce Strategic Collaboration
Exclusive licensing and R&D collaboration between Hovione and Firstgene.
Merck & Co. Breaks Ground on $1 Billion Biologics Center in US
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.
Asahi Kasei: Ken Shinomiya Becomes Leader of Asahi Kasei’s Healthcare Sector
Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, to succeed Richard Packer as Head of Healthcare.
Fujifilm Diosynth Biotechnologies & Regeneron Sign Manufacturing Agreement
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced a 10-year manufacturing supply agreement, valued at over $3 billion (€2.64 billion), with Regeneron Pharmaceuticals to provide US-based production of its industry-leading biologic medicines, which treat millions of patients worldwide.
Asahi Kasei Launches Life Science Division to Boost Bioprocess Innovation
To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.
Seqens and Novonesis Partner for Biocatalytic Processes in Fine Chemicals
The Seqens Group, a global manufacturer of health, personal care, and specialty ingredients, recently announced a strategic partnership with Novonesis, a sustainable biological solutions provider.
Syngene Acquires its First US Manufacturing Facility
Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
AAVs in Focus: Innovative Approaches to Guide Cutting-Edge Gene Therapy
This Article Collection delves into the latest research and applications of adeno-associated viruses (AAVs), highlighting advancements in production, characterization, and purification processes.
